U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928337) titled 'Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.' on March 27.
Brief Summary: This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.
Study Start Date: May 01
Study Type: OBSERVATIONAL
Condition:
Fertility Disorders
Intervention:
DEVICE: AI evaluation of oocytes.
AI ev...